Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil in Rheumatoid Arthritis
NCT07516769Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicorandil in rheumatoid arthritis (RA), sponsored by Tanta University. Started Nov 2024; status: recruiting.
02
Drugs
nicorandil
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07516769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07516769.